Citations Report

Clinical Investigation : Citations & Metrics Report

Articles published in Clinical Investigation have been cited by esteemed scholars and scientists all around the world.

Clinical Investigation has got h-index 28, which means every article in Clinical Investigation has got 28 average citations.

Following are the list of articles that have cited the articles published in Clinical Investigation.

• Rautio, Jarkko, Jussi Kärkkäinen, and Kenneth B. Sloan. "Prodrugs–Recent approvals and a glimpse of the pipeline." European Journal of Pharmaceutical Sciences 109 (2017): 146-161. View at Publisher | View at Google Scholar | View at Indexing
• Norouzi, Parviz, et al. "A Novel Admittometric Sensor for Determination of Theophylline using FFT Coulometric Admittance Voltammetry and Flow Injection Analysis." Int. J. Electrochem. Sci 12.11 (2017): 10057-10070. View at Publisher | View at Google Scholar | View at Indexing
• Xia F. A SIGNATURE ENRICHMENT DESIGN WITH BAYESIAN ADAPTIVE RANDOMIZATION FOR CANCER CLINICAL TRIALS. View at Publisher | View at Google Scholar | View at Indexing
• Matthes, Susann, and Michael Bader. "Peripheral serotonin synthesis as a new drug target." Trends in pharmacological sciences 39.6 (2018): 560-572. View at Publisher | View at Google Scholar | View at Indexing
• Lancet, Elizabeth A. "USING MARGINAL STRUCTURAL MODELS TO CONTROL FOR TIME-DEPENDENT CONFOUNDING AND DETECT EFFECT MODIFICATION IN A RANDOMIZED CONTROL TRIAL WITH A TIME-VARYING EXPOSURE, NON-ADHERENCE AND MISSING DATA." (2019). View at Publisher | View at Google Scholar | View at Indexing
• Mei, Haibo, et al. "Tailor?Made Amino Acids and Fluorinated Motifs as Prominent Traits in Modern Pharmaceuticals." Chemistry–A European Journal 26.50 (2020): 11349-11390. View at Publisher | View at Google Scholar | View at Indexing
• Zhao W, Ma W, Wang F, Hu F. Incorporating covariates information in adaptive clinical trials for precision medicine. Pharmaceutical Statistics. 2021 Aug 9. View at Publisher | View at Google Scholar | View at Indexing
• Neychev, Vladimir, and Electron Kebebew. "Management options for advanced low or intermediate grade gastroenteropancreatic neuroendocrine tumors: review of recent literature." International journal of surgical oncology 2017 (2017). View at Publisher | View at Google Scholar | View at Indexing
• Masab, Muhammad, and Muhammad Wasif Saif. "Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea." Cancer chemotherapy and pharmacology 80.6 (2017): 1055-1062. View at Publisher | View at Google Scholar | View at Indexing
• Joish, V. N., F. Frech, and P. Lapuerta. "Cost-effectiveness analysis of telotristat ethyl for treatment of carcinoid syndrome diarrhea inadequately controlled with somatostatin analogs." Journal of medical economics 21.2 (2018): 182-188. View at Publisher | View at Google Scholar | View at Indexing
• Anthony, Lowell B., et al. "Long?Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome." The oncologist 24.8 (2019): e662. View at Publisher | View at Google Scholar | View at Indexing
• Bader, Michael. "Inhibition of serotonin synthesis: A novel therapeutic paradigm." Pharmacology & therapeutics 205 (2020): 107423. View at Publisher | View at Google Scholar | View at Indexing
• Dillon, Joseph S., and Chandrikha Chandrasekharan. "Telotristat ethyl: a novel agent for the therapy of carcinoid syndrome diarrhea." Future Oncology 14.12 (2018): 1155-1164. View at Publisher | View at Google Scholar | View at Indexing
• Saavedra, Cristina, et al. "Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes." Cancer management and research 11 (2019): 7537. View at Publisher | View at Google Scholar | View at Indexing
• Weaver, Samantha R., et al. "Peripartum dietary supplementation of a small-molecule inhibitor of tryptophan hydroxylase 1 compromises infant, but not maternal, bone." American Journal of Physiology-Endocrinology and Metabolism 315.6 (2018): E1133-E1142. View at Publisher | View at Google Scholar | View at Indexing
• Herrera-Martínez, Aura D., et al. "Effect of the tryptophan hydroxylase inhibitor telotristat on growth and serotonin secretion in 2D and 3D cultured pancreatic neuroendocrine tumor cells." Neuroendocrinology 110.5 (2020): 351-363. View at Publisher | View at Google Scholar | View at Indexing
• Weaver, Samantha R., et al. "Translational Physiology: Peripartum dietary supplementation of a small-molecule inhibitor of tryptophan hydroxylase 1 compromises infant, but not maternal, bone." American Journal of Physiology-Endocrinology and Metabolism 315.6 (2018): E1133. View at Publisher | View at Google Scholar | View at Indexing
• Sommer C, Zuccolin D, Arnera V, Schmitz N, Adolfsson P, Colombo N, Gilg R, McDowell B. Building clinical trials around patients: evaluation and comparison of decentralized and conventional site models in patients with low back pain. Contemporary clinical trials communications. 2018 Sep 1;11:120-6. View at Publisher | View at Google Scholar | View at Indexing
• Konda, Bhavana, and Manisha H. Shah. "Telotristat Ethyl: A Novel Therapy for Carcinoid Syndrome—Not a Panacea but a Step in the Right Direction." View at Publisher | View at Google Scholar | View at Indexing
• O?elea, Marina Ruxandra, et al. "Novel Therapy of the Carcinoid Syndrome Related Diarrhea." Biomedical Journal 1: 6. View at Publisher | View at Google Scholar | View at Indexing
• Weaver, Samantha R., et al. "Peripartum dietary supplementation of a small molecule inhibitor of tryptophan hydroxylase 1 (TPH1) compromises infant, but not maternal, bone." Perturbation of the Peripartum Serotonergic Axis: Outcomes on Maternal and Neonatal Calcium and Bone 1001: 124. View at Publisher | View at Google Scholar | View at Indexing
• Verna EC, Serper M, Chu J, Corey K, Fix OK, Hoyt K, Page KA, Loomba R, Li M, Everson GT, Fried MW. Clinical research in hepatology in the COVID?19 pandemic and post?pandemic era: challenges and the need for innovation. Hepatology. 2020 Nov;72(5):1819-37. View at Publisher | View at Google Scholar | View at Indexing
• Dungen, Fadime Dogan-Oruc, et al. "Efficacy of the tryptophan hydroxylase inhibitor telotristat on growth and serotonin secretion in 2D and 3D cultured neuroendocrine tumor cells." Novel Diagnostic Biomarkers and Therapeutic Options for Neuroendocrine Tumors: 169. View at Publisher | View at Google Scholar | View at Indexing
• Celli, Bartolome R., et al. "Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment." International journal of chronic obstructive pulmonary disease 14 (2019): 1019. View at Publisher | View at Google Scholar | View at Indexing
• Andreas, Stefan, et al. "No influence on cardiac arrhythmia or heart rate from long-term treatment with tiotropium/olodaterol versus monocomponents by holter ECG analysis in patients with moderate-to-very-severe COPD." International Journal of Chronic Obstructive Pulmonary Disease 15 (2020): 1945. View at Publisher | View at Google Scholar | View at Indexing
• Feyman Y, Provenzano F, David FS. Disparities in clinical trial access across US urban areas. JAMA network open. 2020 Feb 5;3(2):e200172-. View at Publisher | View at Google Scholar | View at Indexing
• Gilmer, Todd P., et al. "Predictors of nebulized arformoterol treatment: A retrospective analysis of medicare beneficiaries with chronic obstructive pulmonary disease." COPD: Journal of Chronic Obstructive Pulmonary Disease 16.2 (2019): 140-151. View at Publisher | View at Google Scholar | View at Indexing
• Dehghan Manshadi, Farideh, et al. "Effect of Percutaneous Tibial Nerve Stimulation on Lower Urinary Tract Symptoms in Cerebral Palsy." Journal of Medical Council of Iran 36.2 (2019): 84-89. View at Publisher | View at Google Scholar | View at Indexing
• Bharucha AE, Wi CI, Srinivasan SG, Choi H, Wheeler PH, Stavlund JR, Keller DA, Bailey KR, Juhn YJ. Participation of rural patients in clinical trials at a multisite academic medical center. Journal of Clinical and Translational Science. 2021:1-28. View at Publisher | View at Google Scholar | View at Indexing
• ????? ??????, et al. "????????? ???????? ????? ??? ??????? ??????? ?????? ????? ?????? ?????? ?? ??? ????." ???? ???? ?????? ???? ????? ?????? ?????? ????? 36.2 (2019): 84-89.‎ View at Publisher | View at Google Scholar | View at Indexing
• ?????????, ???? ?????????????. "?????????? ???????? ???????? ??????? ?????????? ???????? ??????? ????? ? ?????." (2018).?????????, ???? ?????????????. "?????????? ???????? ???????? ??????? ?????????? ???????? ??????? ????? ? ?????." (2018).?????????, ???? ?????????????. "?????????? ???????? ???????? ??????? ?????????? ???????? ??????? ????? ? ?????." (2018). View at Publisher | View at Google Scholar | View at Indexing
• Senefeld JW, Johnson PW, Kunze KL, van Helmond N, Klassen SA, Wiggins CC, Bruno KA, Golafshar MA, Petersen MM, Buras MR, Klompas AM. Program and patient characteristics for the united states expanded access program to COVID-19 convalescent plasma. medRxiv. 2021 Jan 1. View at Publisher | View at Google Scholar | View at Indexing
• Grace Cannard, K., et al. "Recruitment and retention in clinical trials of deep brain stimulation in early-stage Parkinson’s disease: past experiences and future considerations." Journal of Parkinson's disease 8.3 (2018): 421-428. View at Publisher | View at Google Scholar | View at Indexing
• Brøgger-Mikkelsen, Mette, et al. "Online patient recruitment in clinical trials: systematic review and meta-analysis." Journal of medical Internet research 22.11 (2020): e22179. View at Publisher | View at Google Scholar | View at Indexing
• Bertram, Wendy, et al. "Optimising recruitment into trials using an internal pilot." Trials 20.1 (2019): 1-8. View at Publisher | View at Google Scholar | View at Indexing
• Radi, Noorzaihan Mat, Tan Bee Ying, and Audrey Ooi. "Attracting Clinical Research to Malaysia with a Centralized Feasibility Platform." View at Publisher | View at Google Scholar | View at Indexing
• Ramalhinho, Ana Cristina, and Miguel Castelo-Branco. "Preparation of an Academic Clinical Trial." DNA Vaccines. Humana, New York, NY, 2021. 317-330. View at Publisher | View at Google Scholar | View at Indexing
• Webb, Nicholas Ja, et al. "Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT." Health Technology Assessment (Winchester, England) 23.26 (2019): 1. View at Publisher | View at Google Scholar | View at Indexing
• Webb, Nicholas Ja, et al. "Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT." Health Technology Assessment (Winchester, England) 23.26 (2019): 1. View at Publisher | View at Google Scholar | View at Indexing
• Berger, Vance W., Adriana C. Burgos, and Omolola A. Odejimi. "Unrecognized Dual Threats to Internal Validity Relating to Randomization." Randomization, Masking, and Allocation Concealment. Chapman and Hall/CRC, 2017. 123-140. View at Publisher | View at Google Scholar | View at Indexing
• Taves, Donald R. "Flexible Minimization: Synergistic Solution for Selection Bias." Randomization, Masking, and Allocation Concealment. Chapman and Hall/CRC, 2017. 229-241. View at Publisher | View at Google Scholar | View at Indexing
• Tsai, Rebecca Nika. Implementation of electronic patient reported outcome measurement in a safety-net radiation oncology clinic: feasibility, initial quality of life outcomes, and social needs assessment. Diss. Boston University, 2020. View at Publisher | View at Google Scholar | View at Indexing
• Koguchi, Dai, et al. "Impact of maintenance therapy using a half dose of the bacillus Calmette–Guérin Tokyo strain on recurrence of intermediate and high-risk nonmuscle invasive bladder cancer: a retrospective single-center study." BMC urology 20.1 (2020): 1-8. View at Publisher | View at Google Scholar | View at Indexing
• Kessler, Samuel J., and Charles L. Bennett. "Attention must be paid: adverse event reporting needs improvement." Clinical Investigation 4.1 (2014): 5-7. View at Publisher | View at Google Scholar | View at Indexing
• ??, et al. "???????????????????????????????." ???? (???) 28.11 (2019): 760. View at Publisher | View at Google Scholar | View at Indexing
• Wang, Mengchuan, et al. "A review study on macrolides isolated from cyanobacteria." Marine drugs 15.5 (2017): 126. View at Publisher | View at Google Scholar | View at Indexing
•  Nehul, Janardhan Namdeo. "Antineoplastic activity of the extracts from a Cyanobacterium Lyngbya bipunctata Lemm." (2021). View at Publisher | View at Google Scholar | View at Indexing
• Clougherty JE, Kinnee EJ, Cardet JC, Mauger D, Bacharier L, Beigelman A, Blake KV, Cabana MD, Castro M, Chmiel JF, Covar R. Geography, generalisability, and susceptibility in clinical trials. The Lancet Respiratory Medicine. 2021 Apr 1;9(4):330-2. View at Publisher | View at Google Scholar | View at Indexing
• Vermeulen, K. "Development and evaluation of HDAC and Hsp90 PET ligands." (2019). View at Publisher | View at Google Scholar | View at Indexing
• Conway M, Malandruccolo D, Hinkel J. MODELING GEOGRAPHIC BARRIERS TO OVARIAN CANCER CLINICAL TRIALS IN PENNSYLVANIA. View at Publisher | View at Google Scholar | View at Indexing